Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer

MLA

Kelly Slocum, et al. “Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer.” Journal of Medicinal Chemistry, vol. 63, no. 22, Sept. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....345804676325a445ebbb9ef600ced79a&authtype=sso&custid=ns315887.

APA

Kelly Slocum, Jianmei Fan, Michael Dore, Palermo Mark G, Zhan Deng, Bakary-Barry Toure, Jorge Garcia-Fortanet, Dyuti Majumdar, Martin F. Hentemann, Nick Keen, Suzanne Zhu, Christopher Towler, Michael Shultz, William R. Sellers, Simon Mathieu, Denise Grunenfelder, Robert Koenig, Douglas C. Bauer, Shumei Liu, … Andriana Jouk. (2020). Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. Journal of Medicinal Chemistry, 63(22).

Chicago

Kelly Slocum, Jianmei Fan, Michael Dore, Palermo Mark G, Zhan Deng, Bakary-Barry Toure, Jorge Garcia-Fortanet, et al. 2020. “Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer.” Journal of Medicinal Chemistry 63 (22). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....345804676325a445ebbb9ef600ced79a&authtype=sso&custid=ns315887.